Literature DB >> 12486876

The family of IL-10-related cytokines and their receptors: related, but to what extent?

Sergei V Kotenko1.   

Abstract

Five novel cytokines (IL-19, IL-20, IL-22 (IL-TIF), IL-24 (human MDA-7, mouse FISP, rat C49A/Mob-5), and IL-26 (AK155)) demonstrating limited primary sequence identity and probable structural homology to IL-10 have been identified. These cellular cytokines, as well as several cytokines encoded in viral genomes (viral cytokines), form a family of IL-10-related cytokines or the IL-10 family. These cytokines share not only homology but also receptor subunits and perhaps activities. Receptors for these cytokines belong to the class II cytokine receptor family. The receptors are IL-10R2 (CRF2-4), IL-22R1 (CRF2-9), IL-22BP (CRF2-10), IL-20R1 (CRF2-8) and IL-20R2 (CRF2-11). Biological activities of these cytokines, receptor utilization and signaling, as well as expression patterns for cytokines and their receptors are summarized. Although data indicate that these cytokines are involved in regulation of inflammatory and immune responses, their major functions remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486876     DOI: 10.1016/s1359-6101(02)00012-6

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  57 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

2.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  Regulation of apoptosis by type III interferons.

Authors:  W Li; A Lewis-Antes; J Huang; M Balan; S V Kotenko
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

4.  Proinflammatory cytokines underlying the inflammation of Crohn's disease.

Authors:  Warren Strober; Fuping Zhang; Atsushi Kitani; Ivan Fuss; Stefan Fichtner-Feigl
Journal:  Curr Opin Gastroenterol       Date:  2010-07       Impact factor: 3.287

5.  Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.

Authors:  Shujian Chang; Jicheng Yang; Weichang Chen; Yufeng Xie; Weihua Sheng
Journal:  Mol Biol Rep       Date:  2010-03-31       Impact factor: 2.316

Review 6.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

7.  Crystal structure of the interferon gamma receptor alpha chain from chicken reveals an undetected extra helix compared with the human counterparts.

Authors:  Zhiguang Ping; Jianxun Qi; Yanling Sun; Guangwen Lu; Yi Shi; Xiaojia Wang; George F Gao; Ming Wang
Journal:  J Interferon Cytokine Res       Date:  2013-11-27       Impact factor: 2.607

Review 8.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

9.  Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.

Authors:  Dorothee Preimel; Heinrich Sticht
Journal:  J Mol Model       Date:  2004-07-09       Impact factor: 1.810

10.  New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells.

Authors:  Joseph Prescott; Pamela Hall; Mariana Acuna-Retamar; Chunyan Ye; Marc G Wathelet; Hideki Ebihara; Heinz Feldmann; Brian Hjelle
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.